NCT01468688 - A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 20, 2012

Primary Completion Date

July 29, 2016

Study Completion Date

July 29, 2016

Conditions

3rd Line GIST

Interventions

DRUG

STI571

DRUG

BKM120

BKM120 combination therapy

Trial Locations (11)

Novartis Investigative Site, Leuven

Novartis Investigative Site, Lyon

Novartis Investigative Site, Villejuif

Seattle Cancer Care Alliance Onc, Seattle

Dana Farber Cancer Institute SC (2), Boston

Novartis Investigative Site, Vancouver

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Leiden

Novartis Investigative Site, Barcelona

Novartis Investigative Site, London

Novartis Investigative Site, Manchester